Cargando…

NF-κB-dependent Mechanism of Action of c-Myc Inhibitor 10058-F4: Highlighting a Promising Effect of c-Myc Inhibition in Leukemia Cells, Irrespective of p53 Status

Due to the frequent contribution in the pathogenesis of different human malignancies, c-Myc is among those transcription factors that are believed to be pharmacologically targeted for cancer therapeutic approaches. In the present study, we examined the anti-leukemic effect of a well-known c-Myc inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayyadi, Mohammad, Safaroghli-Azar, Ava, Safa, Majid, Abolghasemi, Hassan, Momeny, Majid, Bashash, Davood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462502/ https://www.ncbi.nlm.nih.gov/pubmed/32922477 http://dx.doi.org/10.22037/ijpr.2020.112926.14018

Ejemplares similares

Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines
por: Anjam-Najmedini, Ali, et al.
Publicado: (2022)

10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells
por: MU, QITIAN, et al.
Publicado: (2014)

Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519
por: Pourbagheri-Sigaroodi, Atieh, et al.
Publicado: (2020)

PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest
por: Sadeghi, Soroush, et al.
Publicado: (2020)

CDK Blockade Using AT7519 Suppresses Acute Myeloid Leukemia Cell Survival through the Inhibition of Autophagy and Intensifies the Anti-leukemic Effect of Arsenic Trioxide
por: Zabihi, Mitra, et al.
Publicado: (2019)

Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real‐time PCR
por: Yahyazadeh, Reza, et al.
Publicado: (2021)

The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
por: Delshad, Mahda, et al.
Publicado: (2021)

Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity
por: Delshad, Mahda, et al.
Publicado: (2021)

Anticancer Effects of ZnO/CNT@Fe(3)O(4 )in AML-Derived KG1 Cells: Shedding Light on Promising Potential of Metal Nanoparticles in Acute Leukemia
por: Yousefi, Amir-Mohammad, et al.
Publicado: (2022)

C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010)

The DNA Methylation in Neurological Diseases
por: Younesian, Samareh, et al.
Publicado: (2022)

Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors
por: Ibrahim, Dina, et al.
Publicado: (2022)

Stimulatory Effect of Indolic Hormone on As(2)O(3) Cytotoxicity in Breast Cancer Cells: NF-κB-dependent Mechanism of Action of Melatonin
por: Safaroghli- Azar, Ava, et al.
Publicado: (2018)

Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
por: Hakem, Anne, et al.
Publicado: (2011)

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status
por: Suda, Kenichi, et al.
Publicado: (2017)

Humanized c-Myc Mouse
por: Lehmann, Frank M., et al.
Publicado: (2012)

Targeting c-MYC with T-Cells
por: Helm, Florian, et al.
Publicado: (2013)

Getting to grips with c-Myc
por: Eick, Dirk
Publicado: (2018)

Gfi1 upregulates c-Myc expression and promotes c-Myc-driven cell proliferation
por: Zhang, Yangyang, et al.
Publicado: (2020)

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
por: Chen, Bing-Jia, et al.
Publicado: (2014)

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2021)

Involvement Value of FLT-3, c-Myc, STAT3, p27, and HOTAIR Gene Expression in Acute Myeloid Leukemia Patients: A Molecular Perspective to a Novel Leukemogenesis Mechanism
por: Shagerdi Esmaeli, Naser, et al.
Publicado: (2023)

Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers
por: Lee, Moonjung, et al.
Publicado: (2023)

c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease
por: Zheng, Kang, et al.
Publicado: (2017)

Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2021)

The Prognostic Value of Thrombocytopenia in COVID-19 Patients; a Systematic Review and Meta-Analysis
por: Bashash, Davood, et al.
Publicado: (2020)

The c-MYC Protooncogene Expression in Cholesteatoma
por: Palkó, Enikő, et al.
Publicado: (2014)

c-Myc steers translation in lymphoma
por: Cargnello, Marie, et al.
Publicado: (2019)

c-MYC and Epithelial Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2021)

Sequential and Coordinated Actions of c-Myc and N-Myc Control Appendicular Skeletal Development
por: Zhou, Zi-Qiang, et al.
Publicado: (2011)

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
por: Madden, Sarah K., et al.
Publicado: (2021)

Effect of teicoplanin on the expression of c-myc and c-fos proto-oncogenes in MCF-7 breast cancer cell line
por: Ashouri, Saeideh, et al.
Publicado: (2016)

Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: Identification of the c-myc regulatory gene network
por: Reymann, Susanne, et al.
Publicado: (2008)

Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice
por: Jamerson, M H, et al.
Publicado: (2004)

A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors
por: Xu, Ying, et al.
Publicado: (2022)

Dual targeting of p53 and c-Myc selectively eliminates leukaemic stem cells
por: Abraham, Sheela A, et al.
Publicado: (2016)

The pan-cancer lncRNA MILIP links c-Myc to p53 repression
por: Feng, Yu Chen, et al.
Publicado: (2020)

c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53
por: Kaller, Markus, et al.
Publicado: (2023)

Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis
por: Pelengaris, Stella, et al.
Publicado: (2004)

Postnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletion
por: Sanders, Jennifer A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4hgmfhdtijuh0t5b7gdpea449g